Posts by Aubrey Haddach
Originally filed in October 2014, the long-running and high-stakes battle between two powerhouse companies, Amgen and Sandoz, continues to lay out the ground rules for a growing biosimilar …
Aubrey Haddach a member in the Intellectual Property Department of Dinsmore & Shohl LLP. She represents clients ranging from small businesses to Fortune 500 companies. She has experience in all aspects of patent law and related business matters in the U.S. and around the world. She began her career in the labs of biotech and pharmaceutical companies. Her technical knowledge encompasses chemistry, pharmaceuticals, biotechnology, medical device, agrochemical and oil/gas industries. For more information, and to contact Aubrey, please visit her firm profile page.